Efforts to provide a normed standard for what constitutes intimate partner violence, child abuse, and neglect have clashed with attempts to recognize the impact of cultural variability on the experiences of family maltreatment. Contributing to SDGs 3 and 5, this chapter takes on this challenging intersection by answering vital questions about the operationalization of intimate partner violence and child maltreatment, including how to integrate the need for universal standards with considerations of cultural context.
Each year the RELX Environmental Challenge is awarded to projects that best demonstrate how they can provide sustainable access to safe water or sanitation. In the past decade, the company has awarded $750,000 to projects and solutions that improve the world’s water quality and sanitation. This article, using innovative parallax storytelling technology, looks at the tangible impact of the RELX Environmental Challenge.
To mark the tenth anniversary of the RELX Environmental Challenge and the announcement of this year’s winners, we invite you to join us for SDG 6: From here to there - celebrating 10 years of innovation and exploring the next decade of WASH action, to take a look back over the past 10 years and to consider the decade of action ahead - what will it really take to achieve SDG6: clean water and sanitation for all?
An Article in support of SDGs 2 and 3, analysing the effectiveness of multiple micronutrient powders in infants and showing net health benefits of this intervention in most countries, although cost-effectiveness varied in different settings.
This book chapter advances SDGs 3 and 17 by reviewing how to diagnosis mixed dementias.
This book chapter advances SDG 3 and 10 by reviewing the literature on culture and family-based psychological interventions for schizophrenia, bipolar, and related (SBR) psychotic spectrum disorder.
This book chapter advances SDGs 3 and 17 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD). Despite decades of research, no current and reliable test is currently available for the diagnosis of AD. Genetic biomarkers are promising for both diagnostic tools and tailored profiling therapy.
This book chapter advances SDGs 3 and 17 by discussing available data regarding the effects of genetic variants on the clinical and pathological characteristics of “frontotemporal dementia” (FTD). The term “frontotemporal dementia” (FTD) defines a group of related diseases resulting from progressive degeneration of the temporal and frontal lobes. These areas play a significant role in decision-making, behavioral control, emotion, language, and motor functions.
This book chapter advances SDGs 3 and 17 by describing how acute hospital settings can affect the care of patients with dementia. As well as changes to the physical hospital environment, this requires an enhanced focus on key strategies such as reliable identification of cognitive impairment, access to comprehensive geriatric assessment, prevention and management of delirium, and timely discharge planning are included in the chapter.
This book chapter advances SDGs 3 and 17 by reviewing pathological and functional outcomes of both preventative and therapeutic environmental enrichment on commonly used mouse models of amyloid pathology.